DAPTAD Isotopologue Derivatization for Vitamin D Mass Spectrometry

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for quantifying vitamin D using LC/MS/MS have insufficient sensitivity, particularly when analyzing small samples like newborn blood, and there is a need for enhanced analysis throughput.

Innovation Solution

The use of 4-(4′-dimethylaminophenyl)-1,2,4-triazoline-3,5-dione (DAPTAD) isotopologues as derivatization reagents in combination with mass spectrometry for vitamin D analysis, which increases signal intensity and allows for simultaneous quantitative analysis of multiple samples, improving selectivity and throughput.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional derivatization reagents (PTAD) are used with LC/MS/MS, then vitamin D metabolites can be detected, but the sensitivity is insufficient for small samples like newborn blood

Engineering Contradiction:
Improvedetection sensitivityVSAvoidsample amount
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent changes the chemical structure parameters of the derivatization reagent by introducing electron-donating dimethylamino groups and deuterium isotopes. This structural modification increases the ionization efficiency and signal intensity in ESI-MS/MS, enabling detection of vitamin D metabolites in small sample volumes (newborn blood) with sufficient sensitivity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite derivatization reagent (DAPTAD) that combines the reactive triazoline-3,5-dione core with electron-donating dimethylamino substituents and deuterium isotopes. This composite structure provides both high reactivity for derivatization and enhanced ionization properties for sensitive mass spectrometric detection

Inventive Principle:
Principle #40Composite materials

2Productivity

If multiple samples are analyzed separately by LC/MS/MS, then each sample receives adequate analysis time, but the analysis throughput is low

Engineering Contradiction:
Improveanalysis throughputVSAvoidanalysis time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent merges multiple individual sample analyses into a single combined analysis by using isotopologue derivatization reagents that create mass-shifted derivatives. Multiple derivatized samples are mixed and analyzed simultaneously by LC/MS/MS, with each sample's derivatives distinguished by their unique mass-to-charge ratios, thereby increasing throughput while maintaining analysis quality

Inventive Principle:
Principle #5Merging (Combining)

3Measurement precision

If standard derivatization reagents are used, then the analysis procedure is simple, but structural isomers cannot be distinguished

Engineering Contradiction:
Improveisomer discrimination capabilityVSAvoidderivatization reagent complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent applies local quality modification by introducing deuterium isotopes at specific positions of the derivatization reagent structure. This localized isotopic labeling creates distinct mass shifts for different derivatization reactions, enabling the mass spectrometer to distinguish between structural isomers based on their unique mass spectra while maintaining relatively simple derivatization procedures

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly enhances the sensitivity and selectivity of vitamin D analysis, enabling accurate quantification of small samples and distinguishing structural isomers, thereby improving diagnostic capabilities for neonatal vitamin D deficiency and reducing analysis time.

Implementation Method 1

a derivatization step of derivatizing n number of samples by using n types of 4-(4′-dimethylaminophenyl)-1,2,4-triazoline-3,5-dione (DAPTAD) isotopologues respectively as derivatization reagents

Methodology Applied
Scientific EffectDerivatization reaction: Chemical Bonding

Implementation Method 2

an ionization unit that ionizes the vitamin D derivatives separated in the separation unit

Methodology Applied
Scientific EffectIonization: Ionisation

Implementation Method 3

a mass separation unit that separates and detects ions generated in the ionization unit according to mass

Methodology Applied
Scientific EffectMass spectrometry:

Data Source

PatentUS11193948B2Reagent kit and method for derivatizing and quantifying vitamin D using a mass spectrometer
Publication Date: 2021.12.07 JEOL LTD
  • US11193948B2 patent drawing
  • US11193948B2 patent drawing
  • US11193948B2 patent drawing

AI summary

Provided is a method for quantifying vitamin D, with the vitamin D contained in a biological sample being derivatized with a derivatization reagent and being measured with a mass spectrometer, the method including, a derivatization step of derivatizing n number of samples by using n types of 4-(4′-dimethylaminophenyl)-1,2,4-triazoline-3,5-dione (DAPTAD) isotopologues respectively as derivatization reagents, a mixing step of mixing the n types of derivatization samples obtained in the derivatization step, and a quantitative analysis step of subjecting each of the n types of vitamin D derivatives contained in the mixed sample obtained in the mixing step to quantitative analysis using a mass spectrometer.